Ari Gnanasakthy

RTI uses cookies to offer you the best experience online. By clicking “accept” on this website, you opt in and you agree to the use of cookies. If you would like to know more about how RTI uses cookies and how to manage them please view our Privacy Policy here. You can “opt out” or change your mind by visiting: http://optout.aboutads.info/. Click “accept” to agree.

Search Publications

Filter by Year

Filter by Publication Type

Search Results

Review of patient and clinician global assessments in pro labeling (2017-2019)

Quality of life is maintained with ixazomib maintenance in post-transplant newly diagnosed multiple myeloma: The TOURMALINE-MM3 trial

Patient-reported outcome measures in atopic dermatitis and chronic hand eczema in adults

Patient-reported outcome measures in atopic dermatitis and chronic hand eczema in adults

Patient-reported outcomes from two global multicenter clinical trials of children and adults with tropomyosin receptor kinase (TRK) fusion cancer receiving larotrectinib

A review of patient-reported outcomes labeling for oncology drugs approved by the FDA and the EMA (2012-2016)

Measurement equivalence of patient-reported outcome measures migrated to electronic formats: A review of evidence and recommendations for clinical trials and bring your own device

PRM96 - Methods for reporting the patient-reported outcomes version of the common terminology criteria for adverse events (PRO-CTCAE) data in cancer clinical trials

Assessment of patient-reported outcomes in industry-sponsored clinical trials

Secukinumab sustains early patient-reported outcome benefits through 1 year: Results from 2 phase III randomized placebo-controlled clinical trials comparing secukinumab with etanercept

Psoriasis patients with psoriasis area and severity index (PASI) 90 response achieve greater health-related quality-of-life improvements than those with PASI 75-89 response: Results from two phase 3 studies of secukinumab

A review of patient-reported outcome labeling in the United States (2011-2015)

A review of patient-reported outcome labeling in the United States (2011–2015)

FDA PATIENT-REPORTED OUTCOME LABELING OF NOVEL THERAPIES (2011-2015)

OUTCOME ASSESSMENTS OF PRIMARY ENDPOINTS OF NEW DRUGS APPROVED BY THE FDA (2011-2015)

Patient Perceptions of Psoriasis: A Review of the Survey Literature by Geography: A Review of the Survey Literature by Geography [MEETING ABSTRACT PSS27]

Patient-reported outcomes labeling for products approved by the office of hematology and oncology products of the US Food and Drug Administration (2010-2014)

Psychometric validation of the psoriasis symptom diary using phase III study data from patients with chronic plaque psoriasis

Psychometric validation of a patient-reported measure of physical functioning in sporadic inclusion body myositis

Development of the sporadic inclusion body myositis physical functioning assessment